This page lists the SEC filings reported by US VENTURE PARTNERS X LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2022-08-19 | US VENTURE PARTNERS X LP | eFFECTOR Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2022-08-19 | US VENTURE PARTNERS X LP | eFFECTOR Therapeutics, Inc. | 4,341,682 | 10.5% | EDGAR |
| SC 13G/A | 2022-01-27 | US VENTURE PARTNERS X LP | Inari Medical, Inc. | 0 | 0.0% | EDGAR |
| SC 13D | 2021-09-13 | US VENTURE PARTNERS X LP | eFFECTOR Therapeutics, Inc. | 4,672,628 | 11.5% | EDGAR |
| SC 13G | 2021-02-09 | US VENTURE PARTNERS X LP | Inari Medical, Inc. | 5,239,744 | 10.8% | EDGAR |
| SC 13G/A | 2019-02-08 | US VENTURE PARTNERS X LP | ReShape Lifesciences Inc. | 1,458 | 0.0% | EDGAR |
| SC 13G | 2018-02-12 | US VENTURE PARTNERS X LP | ReShape Lifesciences Inc. | 2,740,646 | 8.8% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.